Mesoblast
Price & Volume
Stats
See more52W Range | $7.09-$22 |
Market Cap | $2.1B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $17.1M |
Revenue Growth (YoY) | 458.6% |
Gross Profit (12 Mos) | -$22.7M |
Diluted EPS | -$0.85 |
News
See moreYahoo Finance • 9 days ago
Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
Yahoo Finance • 20 days ago
Mesoblast enters option to issue $50M convertible notes
Yahoo Finance • 20 days ago
Mesoblast Secures Up To US$50 Mln In Convertible Note Agreements With Key Investors
Yahoo Finance • 20 days ago
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
About
CEO | Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons) |
Address | 55 Collins Street, Melbourne, VIC, Australia, 3000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
